{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Rescue+medication", "query": { "intervention": "Rescue medication" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 290, "total_pages": 29, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Rescue+medication&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T18:11:42.704Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01789710", "title": "Contingency Management for Smoking Cessation in Homeless Smokers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking", "Homeless Persons" ], "interventions": [ { "name": "Bupropion", "type": "DRUG" }, { "name": "Nicotine replacement therapy", "type": "DRUG" }, { "name": "Contingency Management", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 25, "start_date": "2013-01", "completion_date": "2014-09", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01789710" }, { "nct_id": "NCT06780111", "title": "Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Esophageal Squamous Cell Carcinoma" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "I-DXd", "type": "BIOLOGICAL" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Levoleucovorin", "type": "DRUG" }, { "name": "5-Fluorouracil (5-FU)", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Sacituzumab tirumotecan", "type": "BIOLOGICAL" }, { "name": "Rescue Medication", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 298, "start_date": "2025-07-30", "completion_date": "2032-01-04", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06780111" }, { "nct_id": "NCT07395232", "title": "An Efficacy and Safety Study of DFL24498 in the Treatment of AKC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Keratoconjunctivitis" ], "interventions": [ { "name": "DFL24498", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" }, { "name": "dexamethasone sodium phosphate (DSP) ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dompé Farmaceutici S.p.A", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 138, "start_date": "2025-12-01", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-04-20", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 8, "location_summary": "Jacksonville, Florida • Miami, Florida • Morrow, Georgia + 5 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Morrow", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07395232" }, { "nct_id": "NCT03890666", "title": "A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol eMDPI DS", "type": "DRUG" }, { "name": "albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 333, "start_date": "2020-10-26", "completion_date": "2021-10-04", "has_results": true, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Los Angeles, California • Stockton, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03890666" }, { "nct_id": "NCT03893175", "title": "Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Impacted Third Molar Tooth", "Pain, Acute" ], "interventions": [ { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 86, "start_date": "2019-05-10", "completion_date": "2022-03-02", "has_results": false, "last_update_posted_date": "2025-07-24", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03893175" }, { "nct_id": "NCT00583869", "title": "Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Post-operative Pain" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "19 Years to 70 Years" }, "enrollment_count": 86, "start_date": "2007-05", "completion_date": "2009-08", "has_results": false, "last_update_posted_date": "2014-01-07", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00583869" }, { "nct_id": "NCT02175771", "title": "Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "FS MDPI", "type": "DRUG" }, { "name": "FLOVENT HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" }, { "name": "albuterol/salbutamol HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 758, "start_date": "2014-07", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Pell City, Alabama + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Pell City", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02175771" }, { "nct_id": "NCT04325802", "title": "Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Pruritus", "Pruritus Chronic", "Dermatitis" ], "interventions": [ { "name": "Naltrexone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2022-12-31", "completion_date": "2024-06", "has_results": false, "last_update_posted_date": "2023-04-04", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04325802" }, { "nct_id": "NCT06563102", "title": "Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Mild Asthma" ], "interventions": [ { "name": "Albuterol/Budesonide", "type": "COMBINATION_PRODUCT" }, { "name": "Albuterol", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 101, "start_date": "2024-09-11", "completion_date": "2026-02-24", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 16, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Lancaster, California + 13 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Lancaster", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Cape Coral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06563102" }, { "nct_id": "NCT00584766", "title": "Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Breast Cancer" ], "interventions": [ { "name": "High-dose chemotherapy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 21, "start_date": "1987-10", "completion_date": "2002-05", "has_results": false, "last_update_posted_date": "2015-05-29", "last_synced_at": "2026-09-02T18:11:42.704Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT00584766" } ] }